Sort by:
77 products
77 products
ONGLYZA
Comparable to: N/A
Active substance: SAXAGLIPTIN
Concentration: 5MG
Presentation: 28TAB
Laboratory: ASTRAZENECA
Origin: Made in Mexico
Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor used in the treatment of type 2 diabetes mellitus. It improves glycemic control by increasing insulin secretion and decreasing glucagon secretion in a glucose-dependent manner. It helps reduce blood sugar levels.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
OZEMPIC .25 Mg Solution for Injection with 1 Pre-filled Pen of 1.5 mL
OZEMPIC .25 Mg Solution for Injection with 1 Pre-filled Pen of 1.5 mL
OZEMPIC .25 Mg Solution for Injection with 1 Pre-filled Pen of 1.5 mL
Comparable to: Wegovy
Active ingredient: Semaglutide
Concentration: 0.25 Mg
Presentation: Solution for Injection, 1 Pre-filled Pen of 1.5 mL
Laboratory: NOVO NORDISK
Origin: Made in Mexico
Ozempic 0.25 mg is an injectable solution with semaglutide, a GLP-1 receptor agonist, used for the control of type 2 diabetes. It helps reduce blood sugar levels, improve insulin secretion, and promote weight loss. It is administered once a week, facilitating disease management.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.
PREDIAL 500MG 150ML SOLUTION (METFORMIN)
Comparable to: Glucophage
Active ingredient: METFORMIN
Concentration: 500MG
Presentation: 150ML SOLUTION
Laboratory: SILANES
Origin: Made in Mexico
Metformin is a fundamental medication for the treatment of type 2 diabetes. It works by reducing glucose production in the liver and improving the body's sensitivity to insulin, which helps to lower blood sugar levels. It is effective for glycemic control and the prevention of long-term complications.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.
Robergen (Metformin) 500 mg
Comparable to: N/A
Active ingredient: Metformin
Concentration: 500 mg per tablet
Presentation: Box with 100 tablets
Laboratory: GENETICA
Origin: Made in Mexico
This brand-name medication is an oral antidiabetic drug used for the treatment of type 2 diabetes mellitus. It primarily acts by reducing glucose production in the liver and improving the body's cells' sensitivity to insulin. It helps control blood sugar levels and may promote weight loss in some patients.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.
RYBELSUS (SEMAGLUTIDE) 14 MG 30 TABLETS
Comparable to: Ozempic
Active ingredient: Semaglutide
Concentration: 14 MG
Presentation: 30 TABLETS
Laboratory: NOVO NORDISK
Origin: Made in Mexico
Semaglutide is a GLP-1 receptor agonist, used for the treatment of type 2 diabetes and chronic weight management. It helps regulate blood sugar levels, decreases appetite, and promotes a feeling of satiety, which contributes to weight loss.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before taking any medication.
SITAGLIPTIN (JANUVIA) 100MG Camber WITH 28 TABLETS
Comparable to: Januvia
Active ingredient: SITAGLIPTIN
Concentration: 100MG
Presentation: 28 TABLETS
Laboratory: CAMBER
Origin: Made in Mexico
Sitagliptin is a DPP-4 inhibitor used for type 2 diabetes. It works by increasing active incretin levels in the body, which improves the pancreas's ability to release insulin and reduce glucagon when sugar levels are high. It contributes to effective glycemic control.
The consumption of this product is the responsibility of those who recommend it and those who use it. Consult your doctor before taking any medication.
SITAGLIPTIN (JANUVIA) CAMBER 50MG C/28 TABLETS
Comparable to: Januvia
Active substance: SITAGLIPTIN
Concentration: 50MG
Presentation: 28 TABLETS
Laboratory: CAMBER
Origin: Made in Mexico
Sitagliptin is a DPP-4 inhibitor used for type 2 diabetes. It works by increasing active incretin levels in the body, which improves the pancreas's ability to release insulin and reduce glucagon when sugar levels are high. It contributes to effective glycemic control.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
SITAGLIPTIN/METFORMIN (Camber) 50MG/850MG C/56 TABLETS
Comparable to: Janumet
Active ingredient: SITAGLIPTIN / METFORMIN
Concentration: 50MG/850MG
Presentation: 56 TABLETS
Manufacturer: CAMBER
Origin: Made in Mexico
This combined therapy of Sitagliptin and Metformin is for patients with type 2 diabetes. Sitagliptin enhances insulin release, and Metformin decreases glucose production in the liver, in addition to improving insulin sensitivity. It offers comprehensive and effective blood sugar control.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.
SITAGLIPTIN/METFORMIN (Neolpharma) 50MG/850MG C/28 TABLETS
Comparable to: Janumet
Active ingredient: SITAGLIPTIN / METFORMIN
Concentration: 50MG/850MG
Presentation: 28 TABLETS
Laboratory: NEOLPHARMA
Origin: Made in Mexico
This Sitagliptin and Metformin combination therapy is for patients with type 2 diabetes. Sitagliptin enhances insulin release and Metformin decreases glucose production in the liver, in addition to improving insulin sensitivity. It offers comprehensive and effective blood sugar control.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
TRAYENTA
Comparable to: N/A
Active ingredient: LINAGLIPTIN
Concentration: 5MG
Presentation: 30TAB
Manufacturer: BOEHRINGER INGELHEIM
Origin: Made in Mexico
Linagliptin is a DPP-4 inhibitor used for the treatment of type 2 diabetes mellitus. It works by increasing levels of incretin hormones, which results in increased insulin release and decreased glucagon production. It helps effectively control blood glucose levels.
The consumption of this product is the responsibility of those who recommend and use it. Consult your doctor before consuming any medication.
TRAYENTA DUO
Comparable to: N/A
Active ingredient: LINAGLIPTIN / METFORMIN
Concentration: 2.5MG/1000MG
Presentation: 30 TAB
Laboratory: BOEHRINGER INGELHEIM
Origin: Made in Mexico
This medication combines Linagliptin and Metformin for the control of type 2 diabetes. Linagliptin is a DPP-4 inhibitor that increases incretins, while Metformin reduces hepatic glucose production and improves insulin sensitivity. Together, they achieve comprehensive glycemic control.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
TRAYENTA DUO
Comparable to: JENTADUETO
Active ingredient: Linagliptin / Metformin
Concentration: 2.5MG / 500MG
Presentation: 30 TABLETS
Laboratory: Boehringer Ingelheim
Origin: Made in Mexico
Combined medication for the treatment of type 2 diabetes. Linagliptin is a DPP-4 inhibitor that increases incretins, while metformin reduces hepatic glucose production and improves insulin sensitivity. Together, they achieve comprehensive and effective glycemic control.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
TRAYENTA DUO
Comparable to: N/A
Active ingredient: Linagliptin / Metformin
Concentration: 2.5/1000MG
Presentation: 60 TABS
Laboratory: BOEHRINGER INGELHEIM
Origin: Made in Mexico
This medication combines Linagliptin and Metformin for type 2 diabetes management. Linagliptin is a DPP-4 inhibitor that increases incretins, while Metformin reduces hepatic glucose production and improves insulin sensitivity. Together, they achieve comprehensive glycemic control.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.
TUKOL-D DIABETES SYR
Comparable to: -
Active ingredient: Dextromethorphan / Guaifenesin
Concentration: 0.2 g / 2.0 g
Presentation: SYRUP, 120 ML
Laboratory: GENOMMA
Origin: Made in Mexico
This over-the-counter product is designed for the relief of common symptoms and personal care, offering practical solutions for everyday life. Consult the instructions for use.
The consumption of this product is the responsibility of whoever recommends it and whoever uses it. Consult your doctor before consuming any medication.

{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>
{
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})"
x-init="document.addEventListener(`eurus:template--18441902293034__social_feeds_Cpq6fi:splide-ready`, () => {
$nextTick(() => {
if (window.innerWidth > 1024) {
$el.closest('.x-container-quickview-content').style.height = $el.offsetHeight + 'px'
}
})
})"
>